Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Grant/Award of 354,454 ELDN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 354,454 | n/a |
| Jan 13, 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 600,000 | n/a |
| Nov 22, 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 1,015,743 | n/a |
| Jun 14, 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 517,454 | n/a |
| May 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 383,299 | n/a |
| Feb 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 300,000 | n/a |
| Feb 2, 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 108,000 | n/a |
| Dec 21, 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Purchase | 2,000 | $9.0K |
| Aug 19, 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Purchase | 4,000 | $24.8K |
| Jun 10, 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Purchase | 3,000 | $24.0K |